OPTN OPTN/UNOS Ethics Committee Spring 2012 Regional Meeting Update Chair, Alexandra Glazier, MPH, JD Vice-Chair, Peter Reese, MD.

Slides:

Advertisements

Similar presentations

OPTN OPO Committee Spring 2012 Regional Meeting Update.

Advertisements

Alexandra K. Glazier, JD, MPH DCD Ethics Next Speaker: Sponsored by.

Alexandra K. Glazier, JD, MPH Why Gift Law Matters: The Law and Ethics of Donor Designation Next Speaker: Sponsored by.

Membership and Personnel Requirements for VCA Programs (Resolution 27) Vascularized Composite Allograft (VCA)Transplantation Committee Sue V. McDiarmid,

Living Donor Committee Update Christie Thomas, MB, FRCP, FASN, FAHA Medical Director, Kidney Transplant Program University of Iowa Hospitals Chair, OPTN/UNOS.

Region 1 Meeting Heung Bae Kim, MD Regional Councillor.

November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.

Proposed Revisions to and Reorganization of Policy 6.0 (Transplantation of Non-Resident Aliens) Sponsors: Ad Hoc International Relations Committee and.

Policy Oversight Committee Update Board of Directors Meeting June 25-26, 2012 Stuart C. Sweet, MD, PhD.

Addressing the Requirements Outlined in the HIV Organ Policy Equity Act Organ Procurement Organization Committee Spring 2015.

UNOS Update Region 8 Kenneth Andreoni, M.D. OPTN/UNOS President April 4, 2014.

OPTN Strategic Plan Maureen McBride United Network for Organ Sharing August 28, 2012.

Proposal to Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Through Solid Organ Transplantation Ad Hoc Disease.

Addressing the Requirements Outlined in the HIV Organ Policy Equity Act Organ Procurement Organization Committee Fall 2014.

OPTN Bylaws Substantive Rewrite of the Bylaws Addressing Review, Actions, and Due Process Sponsored by the Membership and Professional Standards Committee.

Membership & Professional Standards Committee (MPSC) Spring 2014.

Introduction Organ Transplantation Program Update Advisory Committee on Organ Transplantation November 17, 2015 Melissa Greenwald, MD Acting Director Division.

Proposal to Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Through Solid Organ Transplantation Ad Hoc Disease.

1 Proposal to Increase Committee Terms to Three Years Policy Oversight Committee (POC) Fall 2015.

Liver and Intestinal Organ Transplantation Committee Update David Mulligan, MD, Chair OPTN/UNOS Board of Directors Meeting November 12-13, 2014.

1 National Webinar to Review Non-Discussion Agenda Spring 2016 Public Comment If you are logged into the webinar, please enter the audio PIN Please put.

1 List Covered Body Parts Pertaining to Vascularized Composite Allografts (VCAs) VCA Transplantation Committee Spring 2016.

1 Membership and Professional Standards Committee Fall 2015.

Region 2 Meeting Michael Shapiro, MD.  Discuss regional business  Provide updates on OPTN/UNOS committee activities and projects  Discuss and comment.

1 Vascularized Composite Allograft (VCA) Transplantation Committee Fall 2015 Update.

Membership & Professional Standards Committee (MPSC)

Guidance for VCA Deceased Donor Authorization (Resolution 7)

White Paper: Ethical Considerations of Imminent Death Donation

Lewis Teperman, MD Regional Councillor

Updating Primary Kidney Transplant Physician Requirements

Vascularized Composite Allograft (VCA) Transplantation Committee

Guidance on Optimizing VCA Recovery from Deceased Donors

Vascularized Composite Allograft (VCA) Transplantation Committee

OPO Committee Spring 2018.

Pediatric Transplantation Committee

OPTN/UNOS Kidney Transplantation Committee

Organ Procurement Organization Committee Report

Christie Thomas, MD, FRCP, FASN, FAHA Regional Councillor

Vascularized Composite Allograft (VCA) Transplantation Committee

Minority Affairs Committee Update

Modify HOPE Act Variance to Include Other Organs

Action Items from the Kidney Transplantation Committee

OPTN/UNOS Ethics Committee

Operations and Safety Committee

Vascularized Composite Allograft (VCA) Transplantation Committee

Vascularized Composite Allograft (VCA) Transplantation Committee

David Reich, M.D., FACS Regional Councillor

OPO Committee Fall 2014.

OPO Committee Fall 2014.

Membership & Professional Standards Committee

OPTN/UNOS Living Donor Committee

Informed Consent for Kidney Paired Donation

Vascularized Composite Allograft (VCA) Transplantation Committee

Vascularized Composite Allograft (VCA) Transplantation Committee

Vascularized Composite Allograft Transplantation Committee Fall 2014

Living Donor Committee

Living Donor Committee

Living Donor Committee

Vascularized Composite Allograft (VCA) Transplantation Committee

Elizabeth A. Pomfret, MD, PhD Regional Councillor

Patient Affairs Committee

Region 8 Meeting Harvey Solomon, MD

Vascularized Composite Allograft (VCA) Transplantation Committee

Pediatric Transplantation Committee

White Paper: Ethics of Deceased Donor Organ Recovery without Requirement for Explicit Consent or Authorization Ethics Committee.

OPO Committee Fall 2014.

Living Donor Committee

MPSC Transplant Program Performance Measures (Outcome Measures)

Vascularized Composite Allograft (VCA) Transplantation Committee

VCA Committee Update Spring 2015.

Presentation transcript:

OPTN OPTN/UNOS Ethics Committee Spring 2012 Regional Meeting Update Chair, Alexandra Glazier, MPH, JD Vice-Chair, Peter Reese, MD

OPTN Activities Update  Jointly sponsored proposed revisions to Policy 6.0 with the Ad Hoc International Relations Committee Public comment for the proposal ended 1/12/2012 Met jointly with AHIRC and developed final proposal on March 21, 2012 Proposed final language will go to the Board of Directors in June 2012

OPTN  Ethics Committee will work with the OPO Committee to survey UDCD protocols to develop model elements to be included in the protocols. Proposed Activity OPO Committee Uncontrolled DCD (UDCD or Rapid Organ Recovery)

OPTN  The Committee generally supported the revised proposals and identified several opportunities for clarification, which will be forwarded to the OPO Committee DCD Model Elements (redistributed for public comment)

OPTN Concerns with Proposed DCD Model Elements 1/2 1. Support the change in use of term circulatory instead of cardiac in Donation by Circulatory Death. 2. Consent issues remain, including when to contact donor families about potential DCD and first person consent. 3. Committee does not agree with the OPO approaching the donor family before the decision to withdraw treatment or support.

OPTN Concerns with Proposed DCD Model Elements 2/2 4. Ethically inappropriate to make the OPTN the arbiter on how to describe circulatory death. 5. Requirements are clear that the OPO staff should have no role n the end of life care yet common practice currently is not that the patient’s physician obtains consent. Logistical or ethical issue? 6. The Committee supports the requirement that the evaluation for DCD suitability should occur pre-mortem.

OPTN Vascular Composite Allografts (VCA)  Regulation HHS issued a notice in the Federal Register indicating its intent to designate VCAs as organs within the oversight of HRSA and the OPTN. OPTN Final Rule has NOT yet been amended for VCA Committee will assist early stages in the VCA policy development to identify and discuss potential ethical issues.

OPTN Vascular Composite Allografts  Will need policies and oversight : Matching and placement of organs Organ recovery, distribution, and transplantation Membership and program qualifications Data collection and sharing Compliance Professional and public education

OPTN Questions?